| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 165 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 153 |
| 2 | MYCOPHENOLATE MOFETIL | 152 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 149 |
| 4 | TACROLIMUS OINTMENT 0.1% | 149 |
| 5 | PREDNISONE | 132 |
| 6 | CYCLOPHOSPHAMIDE | 82 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 82 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 82 |
| 9 | METHOTREXATE SODIUM | 80 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AXATILIMAB-CSFR | 2 | 0.0123 |
| 1 | BELUMOSUDIL | 17 | 0.0051 |
| 2 | TREOSULFAN | 11 | 0.0040 |
| 3 | CASPOFUNGIN ACETATE | 5 | 0.0032 |
| 4 | PENTOSTATIN | 3 | 0.0029 |
| 5 | LETERMOVIR | 9 | 0.0028 |
| 6 | HYALURONATE SODIUM | 4 | 0.0026 |
| 7 | BUSULFAN | 37 | 0.0023 |
| 8 | ESTRIOL | 4 | 0.0022 |
| 9 | DEFIBROTIDE SODIUM | 6 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 216 |
| 1 | Kinase Inhibitor [EPC] | 110 |
| 2 | Alkylating Drug [EPC] | 103 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 78 |
| 4 | Azole Antifungal [EPC] | 70 |
| 5 | Janus Kinase Inhibitor [EPC] | 69 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 68 |
| 7 | Purine Antimetabolite [EPC] | 38 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 9 | 0.0028 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 22 | 0.0011 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 23 | 0.0011 |
| 4 | Echinocandin Antifungal [EPC] | 8 | 0.0010 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 6 | Antimalarial [EPC] | 7 | 0.0007 |
| 7 | Antiprotozoal [EPC] | 7 | 0.0007 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 68 | 0.0005 |
| 9 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |